Background: There are currently no available standard drugs treating human papillomavirus
(HPV) infection, especially for patients with low-grade cervical lesion. Several therapies are …

Purpose The aim of this study was to systematically review the cost-effectiveness of HPV
vaccination in Asia. Methods We performed a systematic review of papers indexed in …

Background Human papillomavirus (HPV) vaccines have been proven effective against
cervical cancer. However, HPV vaccination is not included in the Chinese immunization …

Abstract Background In China, there are few studies that have reported future estimations for
cancer mortality. Therefore, this study aimed to assess cancer mortality in China and identify …

Objectives Extended high-risk human papillomavirus (hrHPV) genotype testing has recently
been introduced in routine cervical cancer screening. Changes in national and regional …

Abstract Background and Objectives In South Africa, the prevalence of human
papillomavirus (HPV) and associated diseases, such as cervical cancer and genital warts, is …

Objectives China suffers from high burdens of human papillomavirus (HPV) and cervical
cancer, whereas the uptake of HPV vaccine remains low. The first Chinese domestic HPV …

Cervical cancer (CC) is one of the highest prevailing causes of female cancer-related
mortality globally. A significant discrepancy in incidence has been noted between high and …

Abstract Background In Ethiopia, cervical cancer is the second most common cancer among
women of the reproductive age group. Since 2018, the quadrivalent human papillomavirus …

Background Cervical cancer burden in South Asia is among the highest globally. Due to the
lack of national immunization programs, the prevalence of human papillomavirus (HPV) …